K-RAS Antikörper (N-Term)
-
- Target Alle K-RAS (KRAS) Antikörper anzeigen
- K-RAS (KRAS) (GTPase Kras (KRAS))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Ratte, Maus, Drosophila melanogaster
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser K-RAS Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- KRAS antibody was raised against the N terminal of KRAS
- Aufreinigung
- Affinity purified
- Immunogen
- KRAS antibody was raised using the N terminal of KRAS corresponding to a region with amino acids TEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETC
- Top Product
- Discover our top product KRAS Primärantikörper
-
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
KRAS Blocking Peptide, catalog no. 33R-9058, is also available for use as a blocking control in assays to test for specificity of this KRAS antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KRAS antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- K-RAS (KRAS) (GTPase Kras (KRAS))
- Andere Bezeichnung
- KRAS (KRAS Produkte)
- Substanzklasse
- Viral Protein
- Hintergrund
- KRAS is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma.
- Molekulargewicht
- 22 kDa (MW of target protein)
-